Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Dermatologic 1

Conditions

Leukemia 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hematologic Neoplasms 3Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neoplasm, Residual 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Influenza, Human 1HTLV-I Infections 1Graft vs Host Disease 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Renal Cell 1Burkitt Lymphoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 38fludarabine phosphate 34Cyclophosphamide 29Mycophenolic Acid 27Whole-Body Irradiation 23Cyclosporine 23Tacrolimus 21Busulfan 18Antilymphocyte Serum 17Radiotherapy 15Methotrexate 15Filgrastim 14Etoposide 13Flow Cytometry 11Methylprednisolone 10Melphalan 9Bortezomib 9Therapeutics 8Rituximab 8Psychiatric Rehabilitation 8Vorinostat 7Polymerase Chain Reaction 7Cord Blood Stem Cell Transplantation 7tanespimycin 5Transplantation 5Sirolimus 5Lenalidomide 5Gemcitabine 5Everolimus 5sargramostim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × Interferon alpha-2 × Other hematologic neoplasm × Clear all
NCT00038376 2018-10-29

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

M.D. Anderson Cancer Center

Phase 2 Completed
56 enrolled
LymphoidOther hematologic neoplasm

Mycosis Fungoides, Lymphoma, T-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡